Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study. 1994

D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
Evanston Hospital, IL.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004448 Echinomycin A cytotoxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis. Quinomycin A,NSC-526417,NSC 526417,NSC526417
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
August 1990, Investigational new drugs,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
September 1987, Cancer treatment reports,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
January 1991, Medical and pediatric oncology,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
January 1995, Investigational new drugs,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
September 1993, Cancer,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
March 1994, Cancer,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
October 1984, Cancer treatment reports,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
January 1994, Investigational new drugs,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
January 1987, Cancer treatment reports,
D H Shevrin, and T E Lad, and P Guinan, and L J Kilton, and A Greenburg, and P Johnson, and R R Blough, and H Hoyer
April 1992, Investigational new drugs,
Copied contents to your clipboard!